Development and application of key technologies of a novel early warning system for colorectal cancer basing on microbial characteristics

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050167

Enrollment

Unknown

Registered

2021-08-19

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Gold Standard:pathological examination

Index test:new&#32

colorectal&#32

cancer&#32

screening&#32

kit

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed by pathology; 2. Patients with adenomatous intestinal polyp confirmed by pathology; 3. No intestinal diseases: no positive intestinal lesions detected by colonoscopy; 4. The self or his agent is signing the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, brain, blood vessel, respiratory system and other major diseases; 2. Complicated with chronic diseases such as hypertension and diabetes; 3. Complicated with Crohn's disease, ulcerative colitis and other intestinal diseases; 4. Suffering from mental illness or cognitive and communication dysfunction; 5. Used antibiotics, immunosuppressants and intestinal flora regulating drugs within 3 months.

Design outcomes

Primary

Measure	Time frame
Intestinal bacteria;Intestinal fungi;Intestinal virus;	—

Countries

China

Contacts

Public ContactHan Shuwen

Huzhou Central Hospital

shuwenhan985@163.com+86 18768233016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026